STOCK TITAN
  1. Home
  2. News
  3. ICAD

iCAD to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NASHUA, N.H., May 17, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD’s Chairman and Chief Executive Officer, will be participating at the following three virtual investor conferences in May and June:

  • Oppenheimer’s MedTech, Tools & Diagnostics Summit will post a pre-recorded presentation on Wednesday, May 26, 2021.
  • The 2021 Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 will host a live presentation starting at 3:00 p.m. ET.
  • 18th Annual Craig-Hallum Institutional Investor Conference will host virtual 1x1 meetings on June 2, 2021.

Webcasts of all events will be available in the Investor Relations section of the Company’s website, https://www.icadmed.com/financial-news-and-events.html. An audio archive of all the presentations will also be available on the website.

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Jeremy Feffer, LifeSci Advisors
+ 1-212-915-2568
jeremy@lifesciadvisors.com


Stock ICAD logo
Icad Inc

NASDAQ:ICAD

ICAD Rankings

#4813 Ranked by Market Cap
#3880 Ranked by Stock Gains
N/A Ranked by Dividends

ICAD Latest News

Apr 11, 2024
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
Apr 9, 2024
iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
Apr 8, 2024
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
Apr 3, 2024
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
Apr 2, 2024
iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale

ICAD Stock Data

Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Manufacturing
Link
Electronic Technology, Computer Peripherals, Technology Services, Packaged Software, Manufacturing, Small Arms, Ordnance, and Ordnance Accessories Manufacturing

About ICAD

icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.